Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 60,000 shares at $47.52 ($2.8M) on 2020-07-08, disclosed to the SEC on 2020-07-10.
Open-market sale of $2.8M ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.82 | 27,896 | $1.3M | 46.4% |
| 2 | $46.82 | 27,896 | $1.3M | 46.4% |
| 3 | $47.52 | 2,104 | $100K | 3.6% |
| 4 | $47.52 | 2,104 | $100K | 3.6% |
| Total | $46.87 avg | 60,000 | $2.8M | 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |